(390 days)
Venous arterial umbilical access in infants.
Vygon Umbilical Catheter Insertion Tray (2.5 Fr. & 3.5 Fr.)
I am sorry, but based on the provided document, I cannot describe the acceptance criteria and the study that proves the device meets them. The document is an FDA 510(k) clearance letter for a Vygon Umbilical Catheter Insertion Tray, indicating substantial equivalence to a predicate device.
This type of document does not typically contain detailed information about:
- Specific acceptance criteria (performance metrics and thresholds) that Vygon established for their device.
- The design or results of performance studies conducted by Vygon to demonstrate that their device meets those criteria.
- Details about test sets, data provenance, expert qualifications, adjudication methods, MRMC studies, standalone performance, ground truth types, or training set specifics.
The FDA 510(k) clearance process primarily evaluates substantial equivalence to a legally marketed predicate device, rather than requiring extensive de novo performance studies with predefined acceptance criteria in the same way a PMA (Premarket Approval) would. While manufacturers do conduct testing to support their 510(k) submission, the specifics of that testing and the predefined acceptance criteria are not usually detailed in the public-facing clearance letter.
Therefore, without additional information from Vygon's 510(k) submission or dedicated performance studies, I cannot answer your request.
§ 880.5200 Intravascular catheter.
(a)
Identification. An intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings and that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. The device may be constructed of metal, rubber, plastic, or a combination of these materials.(b)
Classification. Class II (performance standards).